Glucagon-like peptide 1 as a regulator of food intake and body weight: therapeutic perspectives

Author： Meier J.J.   Gallwitz B.   Schmidt W.E.   Nauck M.A.  

Publisher： Elsevier

ISSN： 0014-2999

Source： European Journal of Pharmacology, Vol.440, Iss.2, 2002-04, pp. : 269-279

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The central corticotropin-releasing factor and glucagon-like peptide-1 in food intake of the neonatal chick

By Furuse M.   Matsumoto M.   Saito N.   Sugahara K.   Hasegawa S.  

European Journal of Pharmacology, Vol. 339, Iss. 2, 1997-11 ,pp. : 211-213

Elsevier

Access to resources Recommend Favorite

Cardiovascular Effects of Glucagon-Like Peptide 1

By  

Mini Reviews in Medicinal Chemistry, Vol. 11, Iss. 1, 2011-01 ,pp. : 97-105

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic assessment of glucagon-like peptide-1 agonists compared with dipeptidyl peptidase IV inhibitors as potential antidiabetic drugs

By Mentlein Rolf  

Expert Opinion on Investigational Drugs, Vol. 14, Iss. 1, 2005-01 ,pp. : 57-64

Informa Healthcare

Access to resources Recommend Favorite

Glucagon-Like Peptide-1 Synthetic Analogs: New Therapeutic Agents for Use in the Treatment of Diabetes Mellitus

By  

Current Medicinal Chemistry, Vol. 10, Iss. 22, 2003-11 ,pp. : 2471-2483

Bentham Science Publishers

Access to resources Recommend Favorite

Development of Glucagon-Like Peptide-1-Based Pharmaceuticals as Therapeutic Agents for the Treatment of Diabetes

By  

Current Pharmaceutical Design, Vol. 7, Iss. 14, 2001-09 ,pp. : 1399-1412

Bentham Science Publishers

Access to resources Recommend Favorite